BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 31006219)

  • 1. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
    J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
    Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders.
    Yin Z; Wu W; Liu R; Liang X; Yu T; Chen X; Feng J; Guo A; Xie Y; Yang H; Huang M; Tian C; Zhang B; Xu Y
    PeerJ; 2015; 3():e1202. PubMed ID: 26401443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apolipoprotein E gene affects the three-year trajectories of compensatory neural processes in the left-lateralized hippocampal network.
    Ye Q; Su F; Shu H; Gong L; Xie C; Zhang Z; Bai F
    Brain Imaging Behav; 2017 Oct; 11(5):1446-1458. PubMed ID: 27734307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
    Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z
    Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOE ε4 allele is associated with increased frontally mediated neurobehavioral symptoms in amnestic MCI.
    Mikos AE; Piryatinsky I; Tremont G; Malloy PF
    Alzheimer Dis Assoc Disord; 2013; 27(2):109-15. PubMed ID: 22874659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic early changes of Glu and Cho in brain regions affected by different types of subjective cognitive decline and their clinical significance.
    Zeng Z; He J; Yao T
    Medicine (Baltimore); 2023 Dec; 102(49):e36457. PubMed ID: 38065860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
    Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
    Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.
    Vieira RN; Ávila R; de Paula JJ; Cintra MT; de Souza RP; Nicolato R; Malloy-Diniz L; de Miranda DM; de Moraes EN; de Marco LA; Romano-Silva MA; Bicalho MA
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1337-1344. PubMed ID: 26876984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E ε4 Specifically Modulates the Hippocampus Functional Connectivity Network in Patients With Amnestic Mild Cognitive Impairment.
    Zhu L; Shu H; Liu D; Guo Q; Wang Z; Zhang Z
    Front Aging Neurosci; 2018; 10():289. PubMed ID: 30319395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.
    Wang Z; Dai Z; Shu H; Liao X; Yue C; Liu D; Guo Q; He Y; Zhang Z
    Sci Rep; 2017 Mar; 7(1):397. PubMed ID: 28341847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
    Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
    Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.